Latest news
YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research - The Manila TimesThe Manila Times · Tue, 04 Aug 2026 12:19:30 GMTKeratoconus Study Ranks Molecules for Future Corneal Therapy Research - Stock TitanStock Titan · Tue, 04 Aug 2026 12:00:00 GMTPrice to earnings forward of YD Bio Limited – NASDAQ:YDES - TradingViewTradingView · Thu, 30 Jul 2026 18:48:34 GMTYD Bio Ord Shs (YDES) Financial Health: Profitability & Balance Sheet Analysis - TradingKeyTradingKey · Tue, 28 Jul 2026 09:49:03 GMTFive Cancer Types Targeted in YD Bio's Cross-Border Pilot - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMTYD Bio Launches Cross-Border Cancer Testing Pilot with Numia Health to Evaluate Expanded Access to Molecular Diagnostics in Canada - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMTYDES|YD Bio Ord Shs|Price:2.300|Chg%:-0.020 - TradingKeyTradingKey · Mon, 27 Jul 2026 12:39:55 GMTYD Bio Ord Shs (YDES) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Mon, 27 Jul 2026 02:55:56 GMT